Jefferies Assumes Bio-Rad Laboratories at Hold, Lowers Price Target of $315
Portfolio Pulse from Benzinga Newsdesk
Jefferies has assumed coverage of Bio-Rad Laboratories with a Hold rating and has lowered the price target to $315.
June 03, 2024 | 1:18 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Jefferies has assumed coverage of Bio-Rad Laboratories with a Hold rating and has lowered the price target to $315.
The Hold rating and lowered price target from Jefferies suggest a cautious outlook on Bio-Rad Laboratories, which could lead to a short-term negative impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100